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Summary
A total of 240 pigs (initially 11.6 lb and
19 d of age) was used to compare four
different feed-grade antibiotics or antibiotic
combinations in phase I (d 0 to 14 post-
weaning) and phase II (d 14 to 28 post-
weaning) starter pig diets. Apramycin and
carbadox were compared in the phase I
diet. Combinations of tylosin/sulfametha-
zine and neomycin sulfate/oxytetracycline
were compared in the phase II diet. No
differences occurred in pig performance for
the phase I and phase II periods between
the feed-grade antibiotics compared in this
growth assay. Therefore, determination of
appropriate feed-grade antibiotic inclusion
will depend on 1) economics, 2) disease
profile of the herd, and 3) growth response
within a particular producer's herd.
(Key Words: Starter, Performance, Antibi-
otic.)
Introduction
Numerous growth-promoting antibiotics
are available for addition to starter pig
diets. Producers are continually faced with
the challenge of deciding which feed-grade
antibiotics are appropriate for their swine
business. This decision often is based on
nontechnical information and testimonials
rather than research data. Therefore, this
trial had three objectives 1) to compare
apramycin and carbadox inclusion in phase
I (d 0 to 14 postweaning), 2) to compare a
tylosin/sulfathiazole combination and a
neomycin/oxytetracycline combination in
phase II (d 14 to 28 postweaning), and 3)
to determine the appropriate sequence of
feed grade antibiotic usage in phase I and
phase II starter pig diets containing spray-
dried blood products. 
Procedures
A total of 240 pigs (initially 11.6 lb
and 19 d of age) was used in a 28 d growth
trial. The trial consisted of two phases.
Phase I was from d 0 to 14 postweaning,
and phase II was from d 14 to 28 post-
weaning. Pigs were allotted by weight and
placed in 4 ft by 6 ft pens (10 pigs per pen)
in an environmentally controlled nursery
facility on a commercial farm in northeast
Kansas. Each pen contained two nipple
waterers, and pigs were allowed ad libitum
access to feed and water. Pigs were as-
signed to one of four treatments based on
the sequence of feed-grade antibiotic inclu-
sion. Either 150 g/ton apramycin or 50
g/ton carbadox were included in the phase
I diet and a combination of either 100 g/ton
tylosin/100 g/ton sulfamethazine (Tylan-
sulfa) or 100 g/ton neomycin sulfate/100
g/ton oxytetracycline (Neo-terra) in the
phase II diet. Phase I diets were formulat-
ed to contain 1.5% lysine, .42% methionine,
.9% calcium, and .8% phosphorus. The
phase I diets contained 7.5% spray-dried
porcine plasma, 1.75% spray-dried blood
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meal, and 20% dried whey. Phase II diets
were formulated to contain 1.25% lysine,
.34% methionine, .9% calcium, and .8%
phosphorus. The phase II diets contained
10% dried whey and 2.5% spray-dried
blood meal. Phase I diets were fed in
pellet form, and phase II diets were fed in
meal form. Pigs and feeders were weighed
on d 7, 14, 21, and 28 to evaluate ADG,
ADFI, and F/G.
Results and Discussion
No mortality occurred during the 28 d
 growth period. During phase I, no differ-
ences occurred in ADG, ADFI, and F/G
between pigs fed apramycin or carbadox
(Table 3). Phase I feed-grade antibiotic did
not influence phase II performance, and no
interactions occurred between feed-grade
antibiotic sources fed during phases I and
II (Table 5). In addition, no differences
occurred in performances between pigs fed
tylosin/sulfamethazine or neomycin/oxyte-
tracycline in phase II (Table 4). Because of
the similar growth performance, results of
this trial indicate that the choice between
the feed-grade antibiotics used in this study
will depend on economics and risk or
perceived risk of tissue residue. In conclu-
sion, this growth assay provides information
to swine producers to aid in the selection of
feed-grade antibiotics in starter pig diets.
Table 1. Diet Composition
Item       Phase I      Phase II
Corn 45.29 59.26
Soybean meal, (48% CP) 16.13 21.26
Dried whey, edible grade 20.00 10.00
Spray-dried porcine plasma 7.50      —
Spray-dried blood meal 1.75 2.50
Soybean oil 5.00 3.00
Monocalcium phosphate 1.91 1.97
Limestone .69 .83
Antibiotic 1.00 .50
Trace mineral premix .15 .15
Vitamin premix .25 .25
DL-methionine .15 .05
L-lysine HCl .10 .15
Copper sulfate .075 .075
Total 100 100
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Table 2. Feed-Grade Antibiotic Inclusion Levels
Item Inclusion level, g/ton
Phase  I
   Apramycin 150
   Carbadox 50
Phase  II
   Tylosin/sulfamethazine 100/100
   Neomycin sulfate/oxytetracycline 100/100
Table 3. Phase I Performance (d 0 to 14 Postweaning)ab
Item Apramycin Carbadox CV
ADG, lb .57 .57 10.4
ADFI, lb .64 .63 6.7
F/G 1.13 1.12 6.9
aEach value is the mean of 12 pens containing 10 pigs per pen. Pigs were initially 19 d
of age and 11.6 lb.
bNo significant treatment effects.
Table 4. Phase II Performance (d 14 to 28 Postweaning)ab
Item
Tylosin/
sulfamethazine
Neomycin sulfate/
oxytetracycline CV
ADG, lb .92 .93 8.7
ADFI, lb 1.45 1.44 4.9
F/G 1.58 1.57 6.4
aEach value is the mean of twelve pens containing 10 pigs per pen. 
bNo significant treatment effects.
Table 5. Growth Performance d 0 to 28 Postweaningab
           Apramycin                            Carbadox                  
Item
Tylosin/
Sulfac
Neo/
oxyd
Tylosin/
Sulfa
Neo/
oxy CV
ADG, lb .91 .90 .94 .96 8.7
ADFI, lb 1.47 1.41 1.43 1.46 4.9
F/G 1.63 1.59 1.53 1.54 6.4
aDiets were fed in two phases: Phase I (d 0 to 14 postweaning) and Phase II ( d 14 to 28
postweaning). Each value is the mean of six pens containing 10 pigs per pen. Pigs were
initially 19 d of age and 11.6 lb.
bNo significant treatment effects.
cTylosin/sulfamethazine. 
dNeomycin sulfate/oxytetracycline.
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